AA
ELV icon

Apriem Advisors’s Elevance Health ELV Stock Holding History

Apriem Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$60K – 205
2018
Q2 		$60K Buy
+250
New +$57.9K 0.01% 232
2017
Q2 		– Sell
-1,250
Closed -$207K – 252
2017
Q1 		$207K Sell
1,250
-30
-2% -$4.77K 0.06% 121
2016
Q4 		$184K Buy
1,280
+30
+2% +$4.02K 0.05% 125
2016
Q3 		$157K Hold
1,250
– – 0.05% 130
2016
Q2 		$164K Hold
1,250
– – 0.05% 123
2016
Q1 		$174K Sell
1,250
-9
-0.7% -$1.2K 0.07% 102
2015
Q4 		$176K Buy
1,259
+9
+0.7% +$1.24K 0.06% 101
2015
Q3 		$175K Buy
+1,250
New +$188K 0.06% 99

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Apriem Advisors's ELV Position: Q3 2018 in Review

Apriem Advisors sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 250 shares — an estimated $60K sold.

Apriem Advisors first reported a position in ELV in Q3 2015 and held it in 8 quarters. The position peaked at $207K in Q1 2017. 947 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Apriem Advisors reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Apriem Advisors sold 250 Elevance Health shares in Q3 2018, an estimated $60K.
  • Apriem Advisors first reported a position in Elevance Health in Q3 2015 and held it in 8 quarters.
  • Apriem Advisors's Elevance Health position peaked at $207K in Q1 2017.
  • 947 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.